As the 24th CPHI China 2026 finished at Shanghai New International Expo Center, the three-day industry event came to a successful close. The exhibition not only brought together leading professionals from the global pharmaceutical supply chain but also served as a vital hub for connecting domestic and international markets and deepening industrial collaboration. For participating companies, it was not only a platform to showcase their technology and capabilities, but also a valuable opportunity to strengthen customer relationships and expand into new markets. 
Reuniting with old friends, friendship and trust grow stronger once again. 
During the exhibition, numerous long-time clients visited our booth. The presence of these enduring partners not only reflects strong recognition of our past services and product quality, but also signifies a firm commitment to deepening cooperation in the future. Amid a vibrant exchange, both parties reviewed the successful outcomes of previous projects and engaged in in-depth discussions on key industry challenges, including compliance in manufacturing, green pharmaceuticals, and supply chain stability. Although the current situation remains challenging, we believe that each contribution we make together for the pharmaceutical industry will lay a solid foundation for securing a place in the market ahead. 
New customers gather, expanding horizons and opening new chapters of collaboration 
In addition to the presence of long-time friends, the exhibition also attracted a large number of new visitors making their first appearance. Overseas buyers, emerging pharmaceutical companies, and cross-industry partners from Europe, Southeast Asia, the Middle East, and other regions gathered in droves. They stopped by booths to carefully examine companies' core product portfolios, manufacturing solutions, and global supply systems. Through in-depth face-to-face discussions, many new clients highly praised the company's strengths in cost control and responsiveness, expressing strong interest in collaboration on-site. The influx of these new clients not only enriched the company's customer base but also laid a solid foundation for expanding into emerging markets and achieving diversified business growth. 
Ready to launch, a new chapter begins in the second half of the year 
The end of the exhibition is not a conclusion, but rather the beginning of a new round of collaboration. This CHPI journey has yielded rich cooperative outcomes while also providing deep insights into the latest industry trends and evolving customer needs. Looking ahead, the company will transform the leads gathered during the event into concrete actions, with its professional team precisely following up on both new and existing clients to efficiently advance project implementation. 
The second half of 2026 will be a critical phase for evaluating achievements and deepening services. We will continue to uphold the principle of "collaborative success," meeting every customer's expectations with robust technological capabilities, high-quality products and services, and efficient global collaboration. We look forward to joining hands with both new and long-standing partners to jointly address challenges, seize opportunities, and create a promising future of high-quality development in the pharmaceutical industry.